FDA
approval
· 2015-10-28
FDA Approved: ALEVE PM — Supplemental Application (Bayer HealthCare LLC.)
Summary
FDA approved a supplemental application for ALEVE PM (diphenhydramine hydrochloride and naproxen sodium) to support its continued marketing as the combination p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ALEVE PM (DIPHENHYDRAMINE HYDROCHLORIDE AND NAPROXEN SODIUM)